XML 75 R48.htm IDEA: XBRL DOCUMENT
v3.20.4

RESEARCH AND DEVELOPMENT EXPENSES (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2020
RESEARCH AND DEVELOPMENT EXPENSES. |
Schedule of research and development expenses |
|  | Year Ended December 31,
|  | 2020 |  | 2019 |  | 2018
|  | U.S. dollars in thousands
Payroll and related expenses |  | 636 |  | 623 |  | 552
Professional services and consulting fees |  | 1,752 |  | 2,345 |  | 2,297
Share-based payments |  | 883 |  | 671 |  | 872
Clinical and pre-clinical trials |  | 12,569 |  | 12,840 |  | 20,373
Intellectual property development |  | 298 |  | 317 |  | 290
Other |  | 353 |  | 623 |  | 478
|  | 16,491 |  | 17,419 |  | 24,862

X
- Definition The disclosure of research and development expense. [Refer: Research and development expense] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2020-01-01 -Paragraph 10 -Subparagraph e -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_10_e&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition n/a + References No definition available. + Details
Name: | rdhl_IfrsResearchAndDevelopmentAbstract
Namespace Prefix: | rdhl_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration